Journal:
:novelty in biomedicine
0
reza mazhari department of medical genetic, faculty of medicine, and genomic research center, shahid beheshti university of medical sciences, tehran, iran.
reza mirfakhraie department of medical genetic, faculty of medicine, shahid beheshti university of medical sciences, tehran, iran.
mojgan asadi osteoporosis research center, endocrinology and metabolism clinical sciences institute, tehran university of medical sciences, tehran, iran
nasrin alipour olyaei genomic research center, shahid beheshti university of medical sciences, tehran, iran
hamidreza kheiri department of pharmaceutical nanotechnology, school of pharmacy, zanjan university of medical sciences, zanjan, tehran, iran
elham moslemi department of biology, school of basic sciences, islamic azad university, east tehran branch, tehran, iran.
background: type ii diabetes is known as one of the most important, prevalent, and expensive diseases of mankind. late diagnosis and subsequent delayed initiation of treatment or surveillance of patients create a variety of problems for affected individuals. this has raised increasing concerns for public health authorities throughout the world. in the current study, we aimed to find a new appro...